Edward A Metzger Deceased55 Northumberland Dr, Toms River, NJ 08757

Edward Metzger Phones & Addresses

55 Northumberland Dr, Toms River, NJ 08757 (732) 244-0921 (732) 244-0927

4914 Tudor Dr, Cape Coral, FL 33904 (239) 549-6103

Fort Myers, FL

Lee, FL

Mentions for Edward A Metzger

Career records & work history

Medicine Doctors

Edward E. Metzger

Specialties:
Anesthesiology
Work:
Anesthesia Services Lynchburg
1922 Thomson Dr STE D, Lynchburg, VA 24501
(434) 845-5493 (phone) (434) 845-1099 (fax)
Site
Education:
Medical School
University of Toledo College of Medicine
Graduated: 1995
Languages:
English, Spanish
Description:
Dr. Metzger graduated from the University of Toledo College of Medicine in 1995. He works in Lynchburg, VA and specializes in Anesthesiology. Dr. Metzger is affiliated with Virginia Baptist Hospital.

Edward L. Metzger

Specialties:
Emergency Medicine
Work:
Mills Sherman Goodwin & Gilliam Emergency Medicine
1 Medical Vlg Dr, Fort Mitchell, KY 41017
(859) 301-2250 (phone) (859) 301-2022 (fax)
Education:
Medical School
University of Louisville School of Medicine
Graduated: 1984
Languages:
English
Description:
Dr. Metzger graduated from the University of Louisville School of Medicine in 1984. He works in Edgewood, KY and specializes in Emergency Medicine. Dr. Metzger is affiliated with St Elizabeth Healthcare Edgewood.

License Records

Edward Louis Metzger

Address:
2525 Pkwy St, Ft Myers, FL 33919
Licenses:
License #: SL3218157 - Active
Category: Real Estate
Issued Date: Feb 2, 2009
Effective Date: May 20, 2011
Expiration Date: Sep 30, 2018
Type: Sales Associate

Edward Metzger resumes & CV records

Resumes

Edward Metzger Photo 33

Edward L Metzger

Location:
14610 Lake Olive Dr, Fort Myers, FL 33919
Industry:
Law Practice
Work:
Adams, Stepner, Woltermann & Dusing, Pllc
Attorney
Adams, Stepner, Woltermann & Dusing, Pllc May 2009 - Aug 2009
Summer Associate
Alliance Defending Freedom Jun 2008 - Aug 2008
Blackstone Fellow
Adam Internet Jun 2008 - Aug 2008
Attorney
Education:
University of Notre Dame 2007 - 2010
Doctor of Jurisprudence, Doctorates, Law
University of Kentucky 2003 - 2007
Bachelors, Bachelor of Arts, Classics, History
Covington Catholic High School 1999 - 2003
Skills:
Personal Injury Litigation, Courts, Legal Writing, Personal Injury, Civil Litigation, Torts, Litigation, Public Speaking, White Collar Criminal Defense, Negotiation, Legal Research, Corporate Law, Bioethics, Criminal Law, Mentoring, Education Law, Insurance Law
Interests:
Human Rights
Education
Edward Metzger Photo 34

Edward Metzger

Edward Metzger Photo 35

National Accounts Manager

Location:
United States
Edward Metzger Photo 36

Edward Metzger

Location:
United States
Edward Metzger Photo 37

Sales At Douglas Property Mgt

Location:
Fort Myers, Florida Area
Industry:
Real Estate

Publications & IP owners

Wikipedia

Edward Metzger Photo 38

Ed Metzger

Ed Metzger (born January 23, 1946) is an American actor and writer. Metzger is known for portrayals of famous men in history. He has portrayed Albert Einstein ...

Us Patents

Arylthiazolidinedione And Aryloxazolidinedione Derivatives

US Patent:
6399640, Jun 4, 2002
Filed:
Jun 16, 2000
Appl. No.:
09/595802
Inventors:
Soumya P. Sahoo - Old Bridge NJ
Conrad Santini - Warren NJ
Julia K. Boueres - Piscataway NJ
James V. Heck - Scotch Plains NJ
Edward Metzger - Edison NJ
Victoria K. Lombardo - Belle Mead NJ
Assignee:
Merck Co., Inc. - Rahway NJ
International Classification:
A61K 31421
US Classification:
514369, 514376, 548183, 548226
Abstract:
Substituted 5-aryl-2,4-thiazolidinediones or 5-aryl-2,4-oxazolidinediones that also carry a second substituent in the 5-position of the heterocyclic ring are potent agonists of PPAR, and are therefore useful in the treatment, control or prevention of diabetes, hyperglycemia, hyperlipidemia (including hypercholesterolemia and hypertriglyceridemia), atherosclerosis, obesity, vascular restenosis, and other PPAR , and/or mediated diseases, disorders and conditions.

Glucagon Receptor Antagonist Compounds, Compositions Containing Such Compounds And Methods Of Use

US Patent:
8318667, Nov 27, 2012
Filed:
Feb 15, 2010
Appl. No.:
13/202124
Inventors:
Songnian Lin - Monroe NJ, US
Libo Xu - Bridgewater NJ, US
Edward Metzger - Somerset NJ, US
Emma R. Parmee - Scotch Plains NJ, US
Sheryl D. Debenham - Scotch Plains NJ, US
Assignee:
Merck Sharp & Dohme Corp. - Rahway NJ
International Classification:
A61K 38/26
A61P 3/10
C07K 14/605
US Classification:
514 69, 514 72, 530308, 5303892
Abstract:
Glucagon receptor antagonist compounds are disclosed. The compounds are useful for treating type (2) diabetes and related conditions. Pharmaceutical compositions and methods of treatment are also included.

Glucagon Receptor Antagonist Compounds, Compositions Containing Such Compounds And Methods Of Use

US Patent:
8324384, Dec 4, 2012
Filed:
Feb 3, 2010
Appl. No.:
13/148809
Inventors:
Songnian Lin - Monroe NJ, US
Xibin Liao - Edison NJ, US
Edward Metzger - Somerset NJ, US
Emma R. Parmee - Scotch Plains NJ, US
Sheryl D. Debenham - Scotch Plains NJ, US
Assignee:
Merck Sharp & Dohme Corp. - Rahway NJ
International Classification:
C07D 209/08
C07D 209/44
C07D 215/08
C07D 217/06
C07D 401/10
C07D 403/10
C07D 403/12
US Classification:
544316, 544333, 546146, 546165, 5462771, 548251, 5483647, 548482, 548491
Abstract:
Glucagon receptor antagonist compounds are disclosed. The compounds are useful for treating type 2 diabetes and related conditions. Pharmaceutical compositions and methods of treatment are also included.

Glucagon Receptor Antagonist Compounds, Compositions Containing Such Compounds And Methods Of Use

US Patent:
8436015, May 7, 2013
Filed:
Sep 10, 2009
Appl. No.:
13/063820
Inventors:
Songnian Lin - Monroe NJ, US
Christian P. Stevenson - Hoboken NJ, US
Emma R. Parmee - Scotch Plains NJ, US
Libo Xu - Bridgewater NJ, US
Xibin Liao - Edison NJ, US
Edward Metzger - Somerset NJ, US
Rui Liang - East Brunswick NJ, US
Fengqi Zhang - Edison NJ, US
John E. Stelmach - Westfield NJ, US
Assignee:
Merck Sharp & Dohme Corp. - Rahway NJ
International Classification:
A01N 43/42
A61K 31/47
C07D 215/00
US Classification:
514312, 546155
Abstract:
Glucagon receptor antagonist compounds of formula I are disclosed:.

Diazeniumdiolate Cyclopentyl Derivatives

US Patent:
8648058, Feb 11, 2014
Filed:
Feb 10, 2011
Appl. No.:
13/577797
Inventors:
Amjad Ali - Freehold NJ, US
Michael Man-Chu Lo - Edison NJ, US
Edward Metzger - Somerset NJ, US
Lin Yan - Brunswick NJ, US
Assignee:
Merck Sharp & Dohme Corp. - Rahway NJ
International Classification:
A61K 31/655
C07C 245/24
US Classification:
514151, 534552
Abstract:
A compound of formula I,.

Diazeniumdiolate Heterocyclic Derivatives

US Patent:
2013028, Oct 31, 2013
Filed:
Oct 25, 2011
Appl. No.:
13/881929
Inventors:
Amjad Ali - Freehold NJ, US
Michael Man-Chu Lo - Edison NJ, US
Robert K. Baker - Cranford NJ, US
Zhiqiang Guo - Morganville NJ, US
Brent Whitehead - Morristown NJ, US
Timothy J. Henderson - Edison NJ, US
Edward Metzger - Somerset NJ, US
Lin Yan - East Brunswick NJ, US
Shrenik K. Shah - Metuchen NJ, US
James Dellureficio - Millington NJ, US
Jun Wang - Edison NJ, US
International Classification:
C07D 207/12
C07D 205/04
C07D 413/10
C07D 403/10
C07D 307/20
C07D 309/12
C07D 211/44
C07D 401/04
US Classification:
514150, 548531, 546242, 548952, 5462787, 5483641, 548255, 546193, 549475, 549419, 544336, 5482694, 548132, 548144
Abstract:
A compound having the structure: useful for treating hypertension, Pulmonary Arterial Hypertension (PAH), congestive heart failure, conditions resulting from excessive water retention, cardiovascular disease, diabetes, oxidative stress, endothelial dysfunction, cirrhosis, pre-eclampsia, osteoporosis or nephropathy.

Diazeniumdiolate Derivatives

US Patent:
2013029, Nov 7, 2013
Filed:
Jan 12, 2012
Appl. No.:
13/980442
Inventors:
Amjad Ali - Freehold NJ, US
Michael Man-Chu Lo - Edison NJ, US
Edward Metzger - Somerset NJ, US
Shrenik K. Shah - Metuchen NJ, US
James Dellureficio - Scotch Plains NJ, US
Assignee:
Merck Sharp & Dohme Corp. - Rahway NJ
International Classification:
C07C 291/02
US Classification:
514151, 534556
Abstract:
A compound having the structure (I) useful for treating hypertension, pulmonary arterial hypertension, congestive heart failure, conditions resulting from excessive water retention, cardiovascular disease, diabetes, oxidative stress, endothelial dysfunction, cirrhosis, pre-eclampsia, osteoporosis or nephropathy.

Isbn (Books And Publications)

Ralph, First Duke Of Montagu, 1638-1709

Author:
Edward Charles Metzger
ISBN #:
0889464529

NOTICE: You may not use PeopleBackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. PeopleBackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.